58 results
8-K
EX-99.1
PRME
Prime Medicine Inc
10 May 24
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
8:05am
-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, implied
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
could prevent protracted or otherwise meritless litigation that distracts from our primary objective of creating stockholder value over the long term
8-K
EX-99.1
9mt9d8j8k9u7u9bium
1 Mar 24
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
8:01am
8-K
EX-1.1
qeuqjb9li bda3kz55
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
8-K
7ohz2m4pp4drtieja2
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
8-K
ejdu3hr
14 Feb 24
Results of Operations and Financial Condition
4:12pm
8-K
EX-99.1
honl0h03
8 Jan 24
Regulation FD Disclosure
8:01am
S-3
EX-1.2
o4p9pbr
3 Nov 23
Shelf registration
5:23pm
8-K
EX-99.1
mjzzdytvq2
3 Nov 23
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:06pm
8-K
EX-99.2
f3la eg0fa1
7 Aug 23
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:04pm
8-K
EX-99.1
3kbzymor
7 Aug 23
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:04pm
8-K
EX-99.1
ccx2o
17 May 23
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
7:09am
8-K
EX-99.1
utre2sold7z 1y6v2zv
11 May 23
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
8:05am
10-Q
8duh1ozungp n4fh7wa
14 Nov 22
Quarterly report
4:46pm